Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day, to help ...

Sana Biotechnology’s investigational allogeneic islet cell therapy has survived and secreted insulin for more than one year ...

Irvine-based biotech company Eledon Pharmaceutical announced updated data from its islet cell transplant study.

Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...

Tolerance is the holy grail in calming autoimmune disease, a truce in the immune system’s faulty battle against the body’s own fabric. In type 1 diabetes, immune fighters attack beta cells in the ...

Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...

Diabetes is one of the most pressing health concerns of our time, and now Swedish scientists have demonstrated a new potential way to manage the disease. It turns out the eye might be a useful place ...

Differentiating stem cells into high-quality insulin-producing cells on a large scale for therapeutic manufacturing is a common bottleneck in translational research. In a study published in Stem Cell ...

FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo ...

Over the last two and a half decades, advancements in stem cell biology and immunology have improved the potential for cell therapy as a treatment for diabetes. Stem cells from different sources can ...

CARY, N.C. and NEW YORK, March 24, 2026 /PRNewswire/ -- Continuity Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic ...

The team, in collaboration with Shanghai Changzheng Hospital, has conducted regenerative islet transplantation surgeries ...